Skip to main content
    M

    McKesson Corporation (MCK)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $977.75
    +15.87 (+1.65%)

    Market Cap: $113.86B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(34/39)
    Avg Surprise
    +7.47%
    Streak
    9 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$10.77
    Range$10.53 - $11.26
    13 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$10.74+0.3%
    60d ago$10.80-0.3%
    30d ago$10.77+0.0%
    7d ago$10.76+0.1%
    Current$10.77
    Revenue Consensus
    $110.0B
    Range$108.8B - $110.8B
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$11.04
    Range$10.41 - $11.66
    13 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$11.11-0.7%
    60d ago$11.03+0.0%
    30d ago$11.04-0.0%
    7d ago$11.02+0.2%
    Current$11.04
    Revenue Consensus
    $113.2B
    Range$112.1B - $114.2B
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$13.33---
    Dec 26EST
    		-$11.04---
    Sep 26EST
    		-$10.77---
    Jun 26
    Reported Aug 5
    		$9.93$9.44+5.19%Beat+20.2%
    Mar 26
    Reported May 7
    		$11.69$11.57+1.04%Beat+15.5%
    Dec 25
    Reported Feb 4
    		$9.34$9.27+0.76%Beat+16.3%
    Sep 25
    Reported Nov 5
    		$9.86$8.92+10.54%Beat+39.5%
    Jun 25
    Reported Aug 6
    		$8.26$8.15+1.35%Beat+4.8%
    Mar 25
    Reported May 8
    		$10.12$9.83+2.95%Beat+63.8%
    Dec 24
    Reported Feb 5
    		$8.03$7.99+0.50%Beat+3.7%
    Sep 24
    Reported Nov 6
    		$7.07$6.87+2.91%Beat+13.5%
    Jun 24
    Reported Aug 7
    		$7.88$7.21+9.29%Beat+8.4%
    Mar 24
    Reported May 7
    		$6.18$6.36-2.83%Miss-14.0%
    Dec 23
    Reported Feb 7
    		$7.74$7.05+9.79%Beat+12.2%
    Sep 23
    Reported Nov 1
    		$6.23$6.15+1.30%Beat+2.8%
    Jun 23
    Reported Aug 2
    		$7.27$5.87+23.85%Beat+24.7%
    Mar 23
    Reported May 8
    		$7.19$7.12+0.98%Beat+23.3%
    Dec 22
    Reported Feb 1
    		$6.90$6.36+8.49%Beat+12.2%
    Sep 22
    Reported Nov 1
    		$6.06$6.10-0.66%Miss-1.5%
    Jun 22
    Reported Aug 3
    		$5.83$5.30+10.00%Beat+4.9%
    Mar 22
    Reported May 5
    		$5.83$6.04-3.48%Miss+15.4%
    Dec 21
    Reported Feb 2
    		$6.15$5.42+13.47%Beat+33.7%
    Sep 21
    Reported Nov 1
    		$6.15$4.66+31.97%Beat+28.1%
    Jun 21
    Reported Aug 4
    		$5.56$4.14+34.30%Beat+100.7%
    Mar 21
    Reported May 6
    		$5.05$5.05+0.00%Beat+18.3%
    Dec 20
    Reported Feb 2
    		$4.60$4.13+11.38%Beat+20.7%
    Sep 20
    Reported Nov 3
    		$4.80$3.88+23.71%Beat+33.3%
    Jun 20
    Reported Aug 3
    		$2.77$2.39+15.90%Beat-16.3%
    Mar 20
    Reported May 20
    		$4.27$4.10+4.15%Beat+15.7%
    Dec 19
    Reported Feb 4
    		$3.81$3.49+9.17%Beat+12.1%
    Sep 19
    Reported Oct 30
    		$3.60$3.59+0.28%Beat+0.0%
    Jun 19
    Reported Jul 31
    		$3.31$3.01+9.97%Beat+14.1%
    Mar 19
    Reported May 8
    		$3.69$3.66+0.82%Beat+5.7%
    Dec 18
    Reported Jan 31
    		$3.40$3.16+7.59%Beat-0.3%
    Sep 18
    Reported Oct 25
    		$3.60$3.28+9.76%Beat+9.8%
    Jun 18
    Reported Jul 26
    		$2.90$2.89+0.35%Beat+17.9%
    Mar 18
    Reported May 24
    		$3.49$3.56-1.97%Miss+2.0%
    Dec 17
    Reported Feb 1
    		$3.41$2.95+15.59%Beat+11.8%
    Sep 17
    Reported Oct 26
    		$3.28$2.79+17.56%Beat-
    Jun 17
    Reported Jul 27
    		$2.46$2.83-13.07%Miss-
    Mar 17
    Reported May 18
    		$3.42$3.01+13.62%Beat-
    Dec 16
    Reported Jan 25
    		$3.05$2.91+4.81%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.38%
    Forward Annual Dividend$3.76
    Payout Ratio5.89%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+14.85%
    5Y CAGR+13.01%
    MCK dividend history and ex-dividend datesRun MCK in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio23.95EV/EBITDA16.08x
    Price/FCF18.09xFCF Yield5.53%
    Profitability
    Profit Margin1.12%Operating Margin1.35%
    ROE0.00%ROIC100.67%
    Financial Health
    Debt/Equity-2.29xInterest Coverage24.48x
    Current Ratio0.89xQuick Ratio0.52x
    Trading Statistics
    Beta0.30Avg Volume823.39K
    52-Week High$996.8452-Week Low$722.11

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$931.30
    SMA 20$901.82
    SMA 50$891.01
    SMA 200$851.22
    EMA 10$935.11
    EMA 20$915.67
    EMA 50$889.09
    EMA 200$842.15

    MACD

    Line: 20.87Signal: 11.93Hist: 8.93

    ADX

    ADX: 24.6+DI: 35.4-DI: 12.3

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down56.0
    PSAR$895.65

    Bollinger Bands

    Upper Band$974.65
    Lower Band$828.99
    %B Position1615%(Upper)
    Band Width1.02

    RSI (14-Day)

    Overbought
    71.6

    Momentum Oscillators

    Stoch %K97.3
    Stoch %D96.1
    Williams %R-1.4
    ROC (10d)14.5%
    Momentum123.94
    CCI (20d)169.6
    MFI (14d)62.5

    Volatility Measures

    ATR (14d)$22.60(2.3%)
    StdDev (20d)36.42
    Hist Vol25.6%(Moderate)

    Volume Flow

    VWAP$974.12
    OBV2.4M
    AD Line-32.8M
    CMF (20d)0.067

    Volume Metrics

    Avg Vol (20d)803.1K
    Vol Ratio0.9x
    VWMA (20d)$899.44

    Pivot Points

    R3$984.81
    R2$977.14
    R1$969.51
    Pivot Point$961.85
    S1$954.21
    S2$946.55
    S3$938.92

    Advanced Oscillators

    TSI23.82
    Ultimate Osc60.8
    KST42.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$105.38B$96.30B$106.16B$103.15B$97.83B$90.82B$95.29B$93.65B$79.28B$76.36B$80.90B$77.22B
    Cost of Revenue$101.69B$92.25B$102.47B$99.61B$94.55B$87.18B$92.01B$90.40B$76.13B$72.77B$77.75B$74.15B
    Gross Profit$3.69B$4.04B$3.69B$3.54B$3.28B$3.64B$3.28B$3.25B$3.15B$3.58B$3.15B$3.07B
    Operating Expenses$2.37B$1.89B$2.07B$2.13B$2.24B$2.05B$2.06B$2.67B$2.12B$2.37B$2.51B$2.12B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$2.26B$1.80B$2.03B$2.07B$2.20B$1.98B$2.03B$2.50B$2.00B$2.19B$2.51B$2.09B
    Operating Income$1.32B$2.15B$1.62B$1.41B$1.04B$1.59B$1.22B$578.00M$1.03B$1.22B$642.00M$951.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$77.00M$61.00M$63.00M$74.00M$49.00M$45.00M$67.00M$78.00M$75.00M$80.00M$64.00M$61.00M
    Income Before Tax$1.31B$2.13B$1.63B$1.40B$1.05B$1.51B$1.23B$534.00M$1.08B$1.17B$612.00M$916.00M
    Income Tax Expense$276.00M$270.00M$380.00M$232.00M$220.00M$209.00M$298.00M$247.00M$124.00M$340.00M$-18,000,000$213.00M
    Net Income$1.03B$1.85B$1.25B$1.16B$831.00M$1.31B$928.00M$287.00M$960.00M$830.00M$630.00M$703.00M
    EBITDA$1.58B$2.38B$1.88B$1.66B$1.26B$1.71B$1.45B$775.00M$1.33B$1.41B$835.00M$1.13B
    EBIT$1.39B$2.19B$1.69B$1.47B$1.10B$1.56B$1.29B$612.00M$1.16B$1.25B$676.00M$977.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MCK

    Government Contracts

    Gov Obligations (TTM)
    $12.26B
    Gov Obligations / Revenue
    3.0%
    Obligations YoY
    5.5%
    Active Awards
    2,482
    New Awards (TTM)
    2,005
    Avg Remaining Term
    5.3 mo

    Top agency: Department of Veterans Affairs at 96.8% of trailing twelve month obligations across 7 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24026K1002Department of Veterans AffairsDepartment of Veterans Affairs$1.41BNov 1, 2025
    36C24026K1008Department of Veterans AffairsDepartment of Veterans Affairs$1.40BMay 1, 2026
    36C24026K1007Department of Veterans AffairsDepartment of Veterans Affairs$1.19BApr 1, 2026
    36C24026K1001Department of Veterans AffairsDepartment of Veterans Affairs$1.18BOct 1, 2025
    36C24025K1012Department of Veterans AffairsDepartment of Veterans Affairs$1.18BSep 1, 2025
    36C24026K1006Department of Veterans AffairsDepartment of Veterans Affairs$1.18BMar 1, 2026
    36C24026K1003Department of Veterans AffairsDepartment of Veterans Affairs$1.11BDec 1, 2025
    36C24026K1004Department of Veterans AffairsDepartment of Veterans Affairs$1.09BJan 1, 2026
    36C24025K1011Department of Veterans AffairsDepartment of Veterans Affairs$1.08BAug 1, 2025
    36C24026K1005Department of Veterans AffairsDepartment of Veterans Affairs$1.06BFeb 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    McKesson stock: Leerink Partners raises target for McKesson stock to USD 1,070

    Leerink Partners has raised its price target for McKesson stock to $1,070 from $1,030, maintaining an outperform rating. McKesson's fiscal Q1 2027 revenue increased by 7.70% to $105.38 billion...

    ad-hoc-news.de•10/16/26•Bullish

    Baird lifts target for Cencora stock to USD 373.00

    Baird has raised its price target for Cencora stock from USD 370.00 to USD 373.00. The company reported fiscal third-quarter revenue of USD 84.75 billion, a 5.10% increase year-over-year...

    ad-hoc-news.de•10/16/26•Somewhat-Bullish

    Leerink raises target for McKesson stock to USD 1,070.00

    Leerink Partners has increased its target price for McKesson stock to USD 1,070.00, citing the company's strong operating scale and recent financial performance. This adjustment follows McKesson's report of a 7.70%...

    ad-hoc-news.de•10/16/26•Bullish

    Ratification Vote Results: McKesson Members Send a Clear Message – NO!

    Members of UFCW Local 401 working at McKesson have overwhelmingly rejected the company's contract offer, with 95% voting no and an 82% voter turnout. This strong mandate indicates that workers have high expectations...

    UFCW Local 401•10/15/26•Somewhat-Bearish

    McKesson Report Flags Continued Access Disparities in Growing Cell, Gene Therapy Market

    A recent report from McKesson highlights ongoing disparities in patient access to cell and gene therapies, even as this market continues to expand. The report indicates that despite advancements...

    GenomeWeb•10/15/26•Somewhat-Bearish

    MCK Valuation and Fair Value

    P/E
    24.0x
    Forward P/E
    19.7x
    EV/EBITDA
    16.1x
    P/FCF
    18.1x
    PEG
    1.7x
    P/B
    -27.4x
    See GNG's fair value

    MCK Profitability: Margins, ROIC and FCF

    Gross margin
    3.6%
    Operating margin
    1.4%
    Net margin
    1.1%
    ROIC
    100.7%
    ROE
    0.0%
    FCF margin
    1.6%
    FCF yield
    5.5%

    MCK Competitors

    CompanyTicker
    Medtronic PLCMDT
    CVS Health CorpCVS
    Bristol-Myers Squibb CompanyBMY
    Stryker CorporationSYK
    Vertex Pharmaceuticals IncVRTX
    HCA Healthcare, Inc.HCA
    Intuitive Surgical IncISRG
    Sanofi ADRSNY

    Sector: Healthcare

    MCK Analyst Ratings

    Consensus
    Buy
    Analysts
    17
    Strong Buy
    3
    Buy
    10
    Hold
    4
    Sell
    0
    Strong Sell
    0

    MCK Bull Case vs Bear Case

    Bull case

    • MCK earns a 100.7% return on invested capital.
    • MCK beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 76.5% of MCK's analyst ratings are Buy or Strong Buy.

    MCK Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    3.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $10.77
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    MCK Dividend

    Forward yield
    0.4%
    Payout ratio
    5.9%
    3Y DPS growth
    14.8%
    5Y DPS growth
    13.0%
    Pay months
    Jan, Apr, Jul, Oct
    MCK dividend history

    Frequently Asked Questions About MCK

    What is MCK's current dividend yield?

    McKesson Corporation (MCK) has a forward dividend yield of 0.38%.

    Does MCK pay dividends?

    Yes, McKesson Corporation pays dividends with a forward dividend yield of 0.38%.

    What is MCK's P/E ratio?

    McKesson Corporation has a price-to-earnings (P/E) ratio of 23.95.

    What is MCK's market cap?

    McKesson Corporation (MCK) has a market capitalization of $113.86B with a current stock price of $977.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In